SCISIO GENETICS, INC.
Medtech · Private
Integrated Genotyping System (IGS) for NGS-based HLA typing in clinical immunogenetics laboratories, comprising workflows, reagents, and data analysis software with GeMS informatics framework
- Grants
- $2.2M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201520162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · An integrated genotyping approach for HLA and other genetic systems | $957,318 | |
| Federal grant | Department of Health and Human Services · Phase II · An integrated genotyping approach for HLA and other genetic systems | $725,994 | |
| Federal grant | Department of Health and Human Services · Phase II · An integrated genotyping approach for HLA and other genetic systems | $487,863 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1738 | LUVOZO PBC | — | — |
| 1739 | Diopter Technologies | — | — |
| 1740 | DELCATH SYSTEMS, INC. | — | $72M |
| 1741 | SCISIO GENETICS, INC. | — | — |
| 1742 | MIVI Neuroscience, Inc. | — | $67M |
| 1743 | THEIA IMAGING LLC | — | $160K |
| 1744 | APOLLO ENDOSURGERY US INC | — | $176M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.